指南与共识自身免疫性与大疱性皮肤病

欧洲儿童和青少年自身免疫性大疱性疾病管理S2k指南

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents.
指南 / 共识 · J Eur Acad Dermatol Venereol · 2026-02-12

欧洲皮肤病与性病学会(EADV)自身免疫性大疱性疾病工作组制定了儿童和青少年AIBDs诊断、治疗和监测的循证专家共识指南。写作组系统综述文献后,由32名投票专家经三轮结构化反馈以>75%同意阈值形成推荐。指南指出儿童所有AIBDs均有报告,线状IgA皮病(LAD)最常见(42-83%),诊断方法与成人相同,治疗需考虑儿童发育药代动力学和不良反应。

要点

  • 儿童AIBDs罕见且鉴别诊断多,及时诊断和优化管理可预防疾病和治疗相关并发症。
  • 儿童AIBDs诊断方法与成人无差异,线状IgA皮病(LAD)最常见(42-83%)。
  • 治疗推荐需根据儿童发育药代动力学、潜在不良反应及对生活质量的影响进行个体化调整。

核心结论

  • 该指南为首个全面聚焦儿童的AIBDs诊断和管理框架,实施推荐可协调诊疗、减少治疗相关毒性并改善患儿生活质量。

研究设计与样本

  • EADV自身免疫性大疱性疾病工作组发起,写作组系统综述儿童和青少年AIBDs文献,因强证据有限,由核心组和专家组(32名投票专家)经三轮结构化反馈和修订以>75%同意阈值共识形成推荐。

主要发现

  • 所有AIBDs(包括表皮内和表皮下大疱性疾病)在儿童中均有报告,线状IgA皮病(LAD)最常见(42-83%)。
  • 儿童AIBDs的诊断方法与成人无差异。
  • 治疗推荐针对儿童患者调整,考虑发育药代动力学、潜在不良反应以及疾病和治疗对生活质量的影响。

关键数值与推荐

  • 线状IgA皮病(LAD)在儿童AIBDs中最常见,报告比例为42-83%。
  • 共识推荐经32名投票专家以>75%同意阈值形成。

临床怎么用

  • 临床应认识到儿童AIBDs虽罕见但可能严重,及时诊断和优化管理可预防疾病和治疗相关并发症。
  • 儿童AIBDs诊断可参照成人方法,治疗需根据儿童发育药代动力学、潜在不良反应及生活质量影响进行个体化调整。

局限性

  • 文献中强证据有限,推荐主要基于共识而非高质量证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Autoimmune blistering diseases (AIBDs) in children and adolescents present a major challenge in diagnosis and management because of their rarity and the presence of other differential diagnoses with blistering. They are potentially serious, and timely diagnosis and optimal management can help prevent morbidity related to both the diseases and their treatments. METHODS: The Autoimmune Blistering Diseases Task Force of the European Academy of Dermatology and Venereology (EADV) has initiated evidence-based, expert-informed clinical guidelines for the diagnosis, treatment and monitoring of paediatric AIBDs. A writing group conducted a systematic review of the available literature on AIBDs in children and adolescents, and since there is limited strong evidence in the literature, recommendations were formulated by consensus over three rounds of structured feedback and revision by the Core Group and Expert Group of the task force (32 voting experts; >75% agreement threshold). RESULTS: Although all AIBDs-including intra-epidermal and subepidermal blistering disorders-are reported in children, linear IgA dermatosis (LAD) is the most common (42-83%). The diagnostic approach in the paediatric age group does not differ from that in adults. Treatment recommendations are tailored to paediatric patients, taking into account developmental pharmacokinetics, potential adverse effects and the impact of disease and therapy on quality of life. CONCLUSIONS: These guidelines provide the first comprehensive, paediatric-focused framework for the diagnosis and management of AIBDs. Implementing the recommendations should harmonize care, reduce treatment-related toxicity and improve quality of life for affected children while steering future research towards critical knowledge gaps.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Nanda A, Tedbirt B, Bodemer C, et al. European S2k guidelines on management of autoimmune blistering diseases in children and adolescents. J Eur Acad Dermatol Venereol. 2026. PMID: 41678328. doi:10.1111/jdv.70308

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。